Abstract:The potential pathogenetic mechanisms underlying the varied morphology of congenital pulmonary airway malformations (CPAMs) have not been molecularly determined, but a subset have been shown to contain clusters of mucinous cells (MCC). These clusters are believed to serve as precursors for potential invasive mucinous adenocarcinoma, and they are associated with KRAS codon 12 mutations. To assess the universality of KRAS mutations in MCCs, we sequenced exon 2 of KRAS in 61 MCCs from 18 patients, and we found a KRAS codon 12 mutation in all 61 MCCs. Furthermore, all MCCs from a single patient always had the same KRAS mutation, and the same KRAS mutation was also found in non-mucinous lesional tissue. Next generation sequencing of seven MCCs showed no other mutations or copy number variations. Sequencing of 46 additional CPAMs with MCCs revealed KRAS mutations in non-mucinous lesional tissue in all cases. RNA in situ hybridization confirmed widespread distribution of cells with mutant KRAS RNA, even extending outside of the bronchiolar type epithelium. We identified 25 additional CPAMs with overall histologic architecture similar to CPAMs with KRAS mutations but without identifiable MCCs, and we found KRAS mutations in 17 (68%). The histologic features of these KRAS mutated CPAMs included type 1 and type 3 morphology, as well as lesions with an intermediate histologic appearance, and analysis revealed a strong correlation between the specific amino acid substitution and histomorphology. These findings, together with previously published model organism data, suggests that the formation of type 1 and 3 CPAMs is driven by mosaic KRAS mutations arising in the lung epithelium early in development and places them within the growing field of mosaic RASopathies. The presence of widespread epithelial mutation explains late metastatic disease in incompletely resected patients and reinforces the recommendation for complete resection of these lesions.

[New Insight of Craniofacial and Oral Findings of the RASopathies].

New Insights Into the Spectrum of RASopathies: Clinical and Genetic Data in a Cohort of 121 Spanish Patients

RASopathies for Radiologists

RASopathies influences on neuroanatomical variation in children.

Cardiac Phenotype and Gene Mutations in RASopathies

Neurodevelopmental Aspects of RASopathies

Defining the spatial landscape of KRAS mutated congenital pulmonary airway malformations: a distinct entity with a spectrum of histopathologic features

Cardiac Manifestations and Associations with Gene Mutations in Patients Diagnosed with RASopathies

Molecular And Phenotypic Spectrum Of Noonan Syndrome In Chinese Patients

RASopathies Due to De Novo Pathogenic Variants: Clinical Features, Genetic Findings and Outcomes in Nine Neonates Born with Congenital Heart Defects

Syndromic craniosynostosis caused by a novel missense variant in MAP4K4: Expanding the genotype–phenotype relationship in RASopathies

Loss-of-function variants in ERF are associated with a Noonan syndrome-like phenotype with or without craniosynostosis

The Cardiofaciocutaneous Syndrome: From Genetics to Prognostic-Therapeutic Implications

Skeletal defects and bone metabolism in Noonan, Costello and cardio-facio-cutaneous syndromes

Further case of enlarged spinal nerve roots in KRAS-related Noonan syndrome

Targeted/exome sequencing identified mutations in ten Chinese patients diagnosed with Noonan syndrome and related disorders

Oral HRAS Mutation in Orofacial Nevus Sebaceous Syndrome (Schimmelpenning-Feuerstein-Mims-Syndrome): A Case Report With a Literature Survey

The 8th International RASopathies Symposium: Expanding research and care practice through global collaboration and advocacy

Activating Mutations Affecting the Dbl Homology Domain of SOS2 Cause Noonan Syndrome

Expansion of the phenotypic spectrum and description of molecular findings in a cohort of patients with oculocutaneous mosaic RASopathies

Autism spectrum disorder profiles in RASopathies: A systematic review